Abstract
The cardiac arrhythmia is characterized by irregular rhythm of heartbeat which could be either too slow (<60 beats/min) or too fast (>100 beats/min) and can happen at any age. The use of pacemaker and defibrillators devices has been suggested for heart arrhythmias patients. The antiarrhythmic medications have been reported for the treatment of cardiac arrhythmias or irregular heartbeats. The diagnosis, symptoms, and treatments of cardiac arrhythmias as well as the radiofrequency ablation, tachycardia, Brugada syndrome, arterial fibrillation, and recent research on the genetics of cardiac arrhythmias have been described here.
Similar content being viewed by others
References
Cleveland Clinic. (2014). ECG of cardiac arrhythmias. Ohio: Cleveland Clinic. www.clevelandclinicmeded.com/medicalpubs/diseasemanagement/cardiology/cardiacarrhythmias/2014.
Hook, B. G., & Marchlinski, F. E. (1991). Value of ventricular electrogram recordings in the diagnosis of arrhythmias precipitating electrical device shock therapy. Journal of the American College of Cardiology, 17(4), 978–984. doi:10.1016/0735-1097(91)90884-C.
The New York Times. (2014, July 23). Arrhythmias treatment.
Gregoratos, G., Abrams, J., Epstein, A. E., & American College of Cardiology/American Heart Association Task Force on Practice Guidelines/North American Society for Pacing and Electrophysiology Committee to Update the 1998 Pacemaker Guidelines: ACC/AHA/NASPE 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices. (1998). A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/NASPE Committee to Update the 1998 Pacemaker Guidelines). Circulation, 106, 2145–2161.
Zipes, D. P., Wyse, G., Friedman, P. L., et al. (1997). A comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. New England Journal of Medicine, 337, 1576–1583.
Mushlin, A. I., Hall, W. J., Zwanziger, J., Multicenter Automatic Defibrillator Implantation Trial, et al. (1998). The cost-effectiveness of automatic implantable cardiac defibrillators: Results of MADIT. Circulation, 97, 2129–2135.
Moss, A. J., Zareba, W., Hall, J., Multicenter Automatic Defibrillator Implantation Trial II Investigators, et al. (2002). Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. New England Journal of Medicine, 346, 877–888.
Wilkoff, B. L., Cook, J. R., Epstein, A. E., Dual Chamber and VVI Implantable Defibrillator Trial Investigators, et al. (2002). Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: The Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial. JAMA, 288, 3115–3123.
Abraham, W. T., Fisher, W. G., Smith, A. L., et al. (2002). Cardiac resynchronization in chronic heart failure. New England Journal of Medicine, 346, 1845–1853.
Zipes, D. P., DiMarco, J. P., Jackman, W. M., et al. (1995). Guidelines for clinical intracardiac electrophysiological and catheter ablation procedures. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Clinical Intracardiac Electrophysiologic and Catheter Ablation Procedures), developed in collaboration with the North American Society of Pacing and Electrophysiology. Journal of the American College of Cardiology, 26, 555–573.
Tracy, C. M., Masood, A., DiMarco, J. P., et al. (2000). ACC/AHA clinical competence statement on invasive electrophysiology studies, catheter ablation, and cardioversion. Journal of the American College of Cardiology, 36, 1725–1736.
Calkins, H., Sousa, J., El-Atassi, R., et al. (1991). Diagnosis and cure of the Wolff–Parkinson–White syndrome or paroxysmal supraventricular tachycardias during a single electrophysiologic test. New England Journal of Medicine, 324, 1612–1618.
Jackman, W., Wang, X., Friday, K. J., et al. (1991). Catheter ablation of accessory atrioventricular pathways (Wolff–Parkinson–White syndrome) by radiofrequency current. New England Journal of Medicine, 324, 1604–1611.
Marrouche, N. F., Dresing, T., Cole, C., et al. (2002). A circular mapping and ablation of the pulmonary vein for treatment of atrial fibrillation: Impact of different catheter technologies. Journal of the American College of Cardiology, 40, 464–474.
Wyse, D. G., Waldo, A. L., DiMarco, J. P., Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) Investigators, et al. (2002). A comparison of rate control and rhythm control in patients with atrial fibrillation. New England Journal of Medicine, 347, 1825–1833.
Cardiac Arrhythmia Suppression Trial (CAST) Investigators. (1989). Preliminary report: Effect of encainide and flecainide on mortality in a randomized trail of arrhythmia suppression after myocardial infarction. New England Journal of Medicine, 321, 406–412.
Chaudhry, G., Muqtada, M. D., & Haffajee, C. I. (2000). Antiarrhythmic agents and proarrhythmia. Critical Care Medicine, 28, N158–N164.
Coplen, S. E., Antman, E. M., Berlin, J. A., et al. (1990). Efficacy and safety of quinidine therapy for maintenance of sinus rhythm after cardioversion. A meta-analysis of randomized control trials. Circulation, 82, 1106–1116.
Kanagaratnam, L., Tomassoni, G., Schweikert, R., et al. (2001). Ventricular tachycardias arising from the aortic sinus of Valsalva: An under-recognized variant of left outflow tract ventricular tachycardia. Journal of the American College of Cardiology, 37, 1408–1414.
Wilkoff, B. L. (2006). Pacemaker and ICD malfunction—an incomplete picture. JAMA, 295, 1945–1946.
Rajamani, K., Goldberg, A. S., & Wilkoff, B. L. (2014). Shock avoidance and the newer tachycardia therapy algorithms. Cardiology Clinics, 32(2), 191–200. doi:10.1016/j.ccl.2014.01.002.
Bardy, G. H., Lee, K. L., Mark, D. B., Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) Investigators, et al. (2005). Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. New England Journal of Medicine, 352, 225–237.
Benditt, D., Ferguson, D., Grubb, B., et al. (1996). Tilt testing for assessing syncope. Journal of the American College of Cardiology, 28, 263–275.
Buxton, A. E., Lee, K. L., Fisher, J. D., et al. (1999). A randomized study of the prevention of sudden death in patients with coronary artery disease. New England Journal of Medicine, 341, 1882–1890.
Kadish, A., Dyer, A., Daubert, J. P., Defibrillators in Non-Ischemic Cardiomyopathy Treatment Evaluation (DEFINITE) Investigators, et al. (2004). Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. New England Journal of Medicine, 350, 2151–2158.
Hoek, G., Brunekreef, B., Fischer, P., & van Wijnen, J. (2001). The Association between air pollution and heart failure, arrhythmia, embolism, thrombosis, and other cardiovascular causes of death in a time series study brief report. Epidemiology, 12(3), 355–357.
Liew, R. (2014). Almanac 2013: Cardiac arrhythmias and pacing-an editorial overview of selected research that has driven recent advances in clinical cardiology. Acta Cardiology, 69(2), 222–234.
Kuck, K. H., & Hindricks, G. (2014). The year in cardiology 2013: Arrhythmias. European Heart Journal, 35(8), 485–490. doi:10.1093/eurheartj/eht552.
Fogorus, R. N. (2014, Dec 16). Medications for heart arrhythmias, heart disease expert. Free email Letter (www.LetAbout.com), Medical Review Board, Tom Grill Images.
Bigger, J. T., Günter, B., Brown, A. M., Camm, A. J., Carmeliet, E., & Fozzard, H. A. (1991). The Sicilian Gambit. A new approach to the classification of antiarrhythmic drugs based on their actions on Arrhythmogenic mechanisms. Task force of the Working Group on Arrythmias. European Society of Cardiology, 84, 1831.
Sagara, K. (2014). Ventriculo-ventri-cular delay optimization of a cardiac resynchro-nization device. Journal of Arrythmia, 30(6), 413–416. doi:10.1016/j.joa.2014.03.013.
Norishige, M., Mandel, W. J., Kobayashi, Y., & Karagueuzian, H. S. (2014). Cardiac fibrosis as a determinant of ventricular tachyarrhythmias. Journal of Arrythmia, 30(6), 389–394. doi:10.1016/j.joa.2013.12.008.
Sinner, M. F. et al. (2014). Integrating genetic, transcriptional, and functional analyses to identify 5 novel genes for atrial fibrillation. Circulation, 130, 1225–1235. doi:10.1161/CirculationAHA.114.009892.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Fu, Dg. Cardiac Arrhythmias: Diagnosis, Symptoms, and Treatments. Cell Biochem Biophys 73, 291–296 (2015). https://doi.org/10.1007/s12013-015-0626-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12013-015-0626-4